Anderson William A, Domingo-Relloso Arce, Galvez-Fernandez Marta, Schilling Kathrin, Glabonjat Ronald A, Basu Anirban, Nigra Anne E, Gutierrez Orlando M, Scherzer Rebecca, Goldsmith Jeff, Sarnak Mark J, Bonventre Joseph V, Kimmel Paul L, Vasan Ramachandran S, Ix Joachim H, Shlipak Michael G, Navas-Acien Ana
Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, USA.
Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.
Environ Res. 2025 Apr 15;271:121060. doi: 10.1016/j.envres.2025.121060. Epub 2025 Feb 6.
Experimental studies indicate that uranium exposure is toxic to the kidney tubules. We evaluated the association of urinary uranium concentrations with biomarkers of tubule cell dysfunction (alpha-1-microglobulin [A1M], uromodulin [UMOD], epidermal growth factor [EGF]), and tubule cell injury (kidney injury molecule-1 [KIM-1], monocyte chemoattractant protein-1 [MCP-1], and chitinase-3-like protein 1 [YKL-40]), as well as with albuminuria and estimated glomerular filtration rate (eGFR) among participants in the Multi-Ethnic Study of Atherosclerosis (MESA).
We conducted a cross-sectional study that included 461 participants selected for the absence of diabetes, chronic kidney disease (CKD), and cardiovascular disease, evaluated with six kidney tubule biomarker measurements. Urinary uranium concentrations were measured using inductively coupled plasma mass spectrometry in spot urine samples. Linear models were used to determine associations of urinary uranium concentrations with each kidney tubule biomarker, calculated by the geometric mean ratio (GMR), after adjustment for participant's urinary creatinine concentrations, age, sex, race/ethnicity, MESA field center, highest level of education completed, cigarette smoking status, alcohol consumption, body mass index (BMI), albuminuria levels, and eGFR.
Median (interquartile range) urinary uranium concentration was 5.2 (2.9, 10.4) ng/L, and mean (standard deviation) eGFR was 99 (16) mL/min/1.73 m. The adjusted GMRs (95%CI) of KIM-1 and MCP-1 were 1.11 (1.01, 1.22) and 1.10 (1.01, 1.20), respectively per 7.5 ng/L (interquartile range) higher urinary uranium concentration, while no statistically significant associations were observed for YKL-40, A1M, UMOD, EGF, albuminuria, or eGFR. In flexible dose-response models, the associations were positive and largely linear between urinary uranium concentrations and higher KIM-1 and MCP-1.
Among healthy community-living individuals, chronic low-level uranium exposure, as measured in urine, was associated with markers of kidney tubule cell injury. Chronic low-level uranium exposure observed in contemporary US urban centers may adversely affect kidney tubule health and related outcomes.
实验研究表明,接触铀对肾小管有毒性。我们评估了尿铀浓度与肾小管细胞功能障碍生物标志物(α-1-微球蛋白[A1M]、尿调节素[UMOD]、表皮生长因子[EGF])、肾小管细胞损伤生物标志物(肾损伤分子-1[KIM-1]、单核细胞趋化蛋白-1[MCP-1]和几丁质酶-3样蛋白1[YKL-40])之间的关联,以及动脉粥样硬化多族裔研究(MESA)参与者中蛋白尿和估算肾小球滤过率(eGFR)之间的关联。
我们进行了一项横断面研究,纳入了461名无糖尿病、慢性肾脏病(CKD)和心血管疾病的参与者,并对六种肾小管生物标志物进行了测量。采用电感耦合等离子体质谱法测量随机尿样中的尿铀浓度。在调整参与者的尿肌酐浓度、年龄、性别、种族/族裔、MESA现场中心、最高学历、吸烟状况、饮酒量、体重指数(BMI)、蛋白尿水平和eGFR后,使用线性模型确定尿铀浓度与每种肾小管生物标志物之间的关联,以几何平均比(GMR)计算。
尿铀浓度中位数(四分位间距)为5.2(2.9,10.4)ng/L,eGFR均值(标准差)为99(16)mL/min/1.73m²。每尿铀浓度升高7.5ng/L(四分位间距),KIM-1和MCP-1的调整后GMR(95%CI)分别为1.11(1.01,1.22)和1.10(1.01,1.20),而YKL-40、A1M、UMOD、EGF、蛋白尿或eGFR未观察到统计学显著关联。在灵活剂量反应模型中,尿铀浓度与较高的KIM-1和MCP-1之间的关联呈阳性且基本呈线性。
在健康的社区居住个体中,尿中测量的慢性低水平铀暴露与肾小管细胞损伤标志物有关。在美国当代城市中心观察到的慢性低水平铀暴露可能会对肾小管健康及相关结局产生不利影响。